As a 39-amino acid synthetic peptide, tirzepatide is engineered on a modified GIP backbone with integrated GLP-1 receptor activity, representing a fundamentally different pharmacological approach from selective GLP-1 agonists such as semaglutide
Vasoinhibins: endogenous regulators of angiogenesis and vascular function
It most likely stems from semaglutides effects on weight and overall heart health
Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Studies report satisfaction rates exceeding 90% for appropriately selected patients
That is why retatrutide is not currently offered through our medical weight-loss programs